Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
  Division of Sexually Transmitted Diseases
    Program and Training Branch
STD Prevention STD Training Home Links Contact Us Glossary 
STD Prevention
Self-Study Modules
Syphilis
Course Objective
Line separator
Target audience
Line separator
Continuing education
Lessons
Line separator
Epidemiology
Line separator
Pathogenesis and microbiology
Line separator
Clinical manifestations and sequelae
Line separator
Diagnostic methods
Line separator
Patient management / treatment
Line separator
Patient counseling and education
Line separator
Partner management / Public health
Line separator
Case study
Line separator
Resources
Line separator
 
 
 

Self-Study STD Module - Syphilis

Diagnostic Methods (continued)

Serologic Tests for Syphilis

In the absence of darkfield microscopy or a DFA-TP, a presumptive diagnosis of syphilis is possible with the use of two types of serologic tests: nontreponemal and treponemal. The use of only one type of serologic test is insufficient for diagnosis because false-positive nontreponemal test results may occur secondary to various medical conditions.

 

Nontreponemal tests

Nontreponemal tests include VDRL (Venereal Disease Research Laboratory), RPR (Rapid Plasma Reagin), TRUST (Toluidine Red Unheated Serum Test), and USR (Unheated Serum Reagin). These tests measure IgM and IgG antibody and are not specific for T. pallidum.

Nontreponemal test titers usually correlate with disease activity, and the results are reported quantitatively. A fourfold change in titer, equivalent to a change of two dilutions (e.g., from 1:16 to 1:4 or from 1:8 to 1:32) is considered necessary to demonstrate a clinically significant difference. Sequential serologic tests in individual patients should be performed by using the same testing method (e.g., VDRL or RPR), preferably by the same laboratory.

The VDRL and RPR are equally valid assays, but quantitative results from the two tests cannot be compared directly because RPR titers are often slightly higher than VDRL titers. TRUST is similar to RPR and USR is similar to VDRL.

Nontreponemal tests usually become nonreactive with time after treatment. In some patients, however, nontreponemal antibodies can persist at a low titer for a long period of time, sometimes for the life of the patient. This response is referred to as the "serofast reaction."

Some clinical laboratories and blood banks have begun to screen samples using treponemal EIA tests. This strategy will identify both persons with previous treatment and persons with untreated or incompletely treated syphilis. False-positive results can occur, particularly among populations with a low prevalence of syphilis.

Persons with a positive treponemal screening test should have a standard nontreponemal test with titer to guide patient management decisions. If the nontreponemal test is negative, then a different treponemal test should be performed to confirm the results of the initial test. If a second trepomenal test is positive, treatment decisions should be discussed in consultation with a specialist.

Advantages of serologic nontreponemal tests:

  • Rapid.
  • Inexpensive.
  • Can use plasma rather than serum (RPR, TRUST).
  • Easy to perform.
  • Can be done in clinic or office.
  • Quantitative.
  • Can be used to follow response to therapy and evaluate possible reinfection.

Disadvantages of serologic nontreponemal tests:

  • May be insensitive in certain stages (particularly early primary, late latent, and tertiary (late)).
  • False-positive reactions can occur (see section on false-positive reactions at the bottom of this page).
  • Rarely, a phenomenon called the “prozone effect” may cause a false-negative reaction. The prozone effect occurs when the reaction is overwhelmed by antibody excess. It is most likely to occur in secondary syphilis. If clinical suspicion of secondary syphilis is high, the lab should titer the sample or dilute the serum to a 1/16 dilution and repeat the qualitative test to rule out the prozone effect.

Treponemal tests

The treponemal tests include TP-PA (T. pallidum particle agglutination), FTA-ABS (fluorescent treponemal antibody absorbed), and EIA (enzyme immunoassay). These tests measure antibody directed against T. pallidum antigens by particle agglutination (TP-PA), immunofluorescence (FTA-ABS), or enzyme reaction (EIA).

These qualitative tests are most often reactive for life, even after adequate treatment. However, 15%-25% of patients treated during the primary stage revert to being serologically nonreactive after 2-3 years. Treponemal antibody titers correlate poorly with disease activity, and they should not be used to assess treatment response.

The following chart compares the sensitivity of various serological tests by stage of syphilis.

(Click on image for larger view)
Sensitivity of Serological Tests in Untreated Syphilis

False-positive reactions

False-positive reactions can occur with both nontreponemal and treponemal serologic tests for syphilis.  The following slide lists causes of false-positive reactions for various serologic tests.  In addition to those listed on the slide, technical errors and transient unknown causes can lead to false-positive reactions in treponemal and nontreponemal tests.

(Click on image for larger view)
Sensitivity of Serological Tests in Untreated Syphilis

 

 
Click here for a Study Question
 
 
Page 10 of 19 BackStatusStatusNext
Page last modified: June 3, 2009
Page last reviewed: June 3, 2009

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 


STD Home
| STD Index

CDC Home | Search | Health Topics A-Z

Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
     Division of Sexually Transmitted Diseases Prevention